- Home
- HUMA
HUMA
Humacyte Inc.
as 05-09-2025 4:00pm EST
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
Upcoming Earnings Alert:
Get ready for potential market movements as Humacyte Inc. HUMA prepares to release earnings report on 13 May 2025.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 221.8M | IPO Year: | N/A |
| Target Price: | $14.60 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.15 - $9.97 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 1178.20% |
Latest Humacyte Inc. News
HUMA Breaking Stock News: Dive into HUMA Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 hours ago
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025
Simply Wall St.
9 days ago
Humacyte Insiders Placed Bullish Bets Worth US$949.4k
TipRanks
a month ago
Lululemon reports Q4 beat, CoreWeave IPO priced at $40: Morning Buzz
TipRanks
a month ago
Humacyte price target lowered to $8 from $10 at BTIG
GlobeNewswire
a month ago
Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
GlobeNewswire
a month ago
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025
GlobeNewswire
a month ago
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
GlobeNewswire
a month ago
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
Compare HUMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HUMA Humacyte Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.